Streetbeat News

Partnerships

SURG

SurgePays, Inc. (NASDAQ:SURG) has announced an exclusive partnership with ClearLine Mobile, Inc. to launch a customer-facing LCD tablet interface for convenience store checkout registers. The tablets will be integrated into the SurgePays software platform and will market SurgePays products 24/7. The company expects the tablets to drive higher revenue per store and expand its presence nationwide.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2023 | 12:46 pm

DYAI

Dyadic International and Byorna have entered into a development and commercialization agreement to work on disruptive bioproduction technologies that will exploit the therapeutic potential of messenger RNA.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2023 | 12:38 pm

ARCT

Arcturus Therapeutics and the Cystic Fibrosis Foundation have extended their ongoing agreement, with the latter increasing its financial commitment to approximately $25M to advance ARCT-032, a treatment for Cystic Fibrosis.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2023 | 12:36 pm

BB

Mitsubishi Electric has chosen BlackBerry's IVY platform to power its new in-vehicle system, FLEXConnect. The collaboration aims to improve road safety by using sensor data to anticipate safety risks, reduce driver distractions, and highlight potential driving hazards.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2023 | 12:29 pm

MO

PEP

Canadian marijuana and liquor retail company, 1CM Inc., has expanded its retail portfolio to include tobacco, vape, and consumer packaged goods products. The company has started retailing cigarettes and vape products as an authorized retailer of Imperial Tobacco Canada, a subsidiary of British American Tobacco, and Rothmans Benson & Hedges, a subsidiary of Altria. It has also begun retailing CPG products from PepsiCo, Frito-Lay, Parmalat & Canada Bread. Additionally, 1CM has started producing its private label Vodka and Vodka Iced Tea under the brand 'EPIC MILFF'.

Portfolio Pulse from Nina Zdinjak

September 26, 2023 | 12:22 pm

PTIX

Protagenic Therapeutics has initiated a Phase I/IIa clinical trial for PT00114, a synthetic version of the naturally occurring brain peptide TCAP. The trial aims to evaluate the therapeutic potential of PT00114 in treating neuro-psychiatric conditions, including depression, anxiety, and PTSD. The study will recruit 56 subjects and will be managed by Axiom Real-Time Metrics.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2023 | 12:20 pm

PBLA

Panbela Therapeutics (NASDAQ:PBLA) has announced the issuance of a new patent in China for a novel process for the production of SBP-101, a lead investigational product. The patent, developed in collaboration with Syngene International Ltd., reduces the number of synthetic steps from seventeen to six, making the production more scalable, efficient, and cost-effective. The patent is valid until 2039 and is expected to improve the overall competitiveness of SBP-101 in the market.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2023 | 12:19 pm

BLNK

Blink Charging has announced an agreement to integrate over 4,000 of its EV charging locations onto the Parkopedia platform in North America. This partnership will increase the visibility and accessibility of Blink's charging stations.

Portfolio Pulse from Bill Haddad

September 26, 2023 | 12:17 pm

MRNA

VGK

The European Union is in discussions with Moderna Inc. for a new deal to secure additional doses of its COVID-19 vaccine. The deal is expected to include the purchase of new versions of the vaccine that could be more effective against variants of the virus.

Portfolio Pulse from Charles Gross

September 26, 2023 | 12:17 pm

BAH

Booz Allen Hamilton (BAH) has invested in HiddenLayer to enhance its adversarial AI capabilities. The investment will scale up Booz Allen's ability to protect federal AI missions through HiddenLayer's MLSec platform.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2023 | 12:11 pm